Hepatic and pancreatic damage produced by cytotoxic drugs

Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes.

Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology·2000

A phase II trial of CI-958 in patients with hormone-refractory prostate cancer.

Cancer chemotherapy and pharmacology·1999

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.

Investigational new drugs·1996

Continuous infusion 5-fluorouracil with bolus adriamycin and mitomycin and low-dose cisplatin (FAMP) in the treatment of metastatic gastric carcinoma: an evaluation of efficacy and toxicity.

Cancer investigation·1991

Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study.

Journal of the National Cancer Institute·1990

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1990

MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.

Cancer treatment reviews·2026

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies.

Cancer treatment reviews·2026

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Cancer treatment reviews·2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Cancer treatment reviews·2026

Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

Cell cycle (Georgetown, Tex.)·2026

Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.

Aging medicine (Milton (N.S.W))·2026

Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

International journal of nanomedicine·2026

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International journal of pharmaceutics: X·2026

Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.

Materials today. Bio·2026

Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

Materials today. Bio·2026

Related Experiment Videos

Hepatic and pancreatic damage produced by cytotoxic drugs

Related Concept Videos

Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes.

A phase II trial of CI-958 in patients with hormone-refractory prostate cancer.

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma.

Continuous infusion 5-fluorouracil with bolus adriamycin and mitomycin and low-dose cisplatin (FAMP) in the treatment of metastatic gastric carcinoma: an evaluation of efficacy and toxicity.

Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study.

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.

MTAP loss in non-small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A-PRMT5 axis.

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

Insights Into the Mechanisms of Biological Aging That Guide Translational and Clinical Research.

Depletion of Soluble PD-L1 with Engineered Nanoparticles Promotes Antitumor Immunity and Tumor Control.

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

Enhanced anticancer efficacy of Pa-MAP 1.9 peptide-coated silver nanostars on breast cancer cells.

Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer.

Related Experiment Videos

Hepatic and pancreatic damage produced by cytotoxic drugs

Related Concept Videos

Related Articles